G protein-coupled receptor kinases (GRKs) are a family of serine/threonine protein kinases that specifically recognize agonist-occupied, activated G protein-coupled receptor proteins as substrates. Phosphorylation of an activated receptor by a GRK terminates signaling, or desensitizes, that receptor by initiating the uncoupling of the receptor from heterotrimeric G proteins. The applicants have demonstrated that one of the GRKs (betaARK1) is expressed in osteoblasts. The role of this GRK in bone biology is unknown, however. Parathyroid hormone (PTH) plays a critical role in a variety of disorders of bone and mineral metabolism. It exerts a dose-dependent effect on the skeleton; given intermittently and in low doses, it is anabolic; in larger doses, it induces bone loss. For rational use in osteoporosis therapy, PTH should be administered in a manner which avoids desensitization. In this application, the following hypotheses are proposed for testing: (1) the rapid phase of desensitization seen in response to PTH is, in part, due to phosphorylation of the PTH receptor by a GRK, such as betaARK1 (beta-adrenergic receptor kinase1); and (2) the betaARK1 gene is involved in regulating the proliferative/differentiative response to PTH in osteoblasts. To test these hypotheses, studies are described with the following Specific Aims: (1) to correlate the effects of deletion of the betaARK gene on desensitization of the adenylyl cyclase response to PTH and phosphorylation of the PTH/PTHrP receptor; (2) to evaluate the ability of betaARK1 to phosphorylate the PTH/PTHrP receptor in membranes from HEK 293 cells with overexpression of the receptor; and (3) to evaluate the effect of deletion of the betaARK1 gene on the proliferative responsiveness and differentiation paradigm of osteoblasts.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK054415-02
Application #
2906280
Study Section
Orthopedics and Musculoskeletal Study Section (ORTH)
Program Officer
Margolis, Ronald N
Project Start
1998-08-31
Project End
2001-07-31
Budget Start
1999-08-15
Budget End
2000-07-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Bliziotes, M; Eshleman, A; Burt-Pichat, B et al. (2006) Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells. Bone 39:1313-21
Schutzer, W E; Reed, J F; Bliziotes, M et al. (2001) Upregulation of G protein-linked receptor kinases with advancing age in rat aorta. Am J Physiol Regul Integr Comp Physiol 280:R897-903
Bliziotes, M M; Eshleman, A J; Zhang, X W et al. (2001) Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake. Bone 29:477-86
Bliziotes, M; Gunness, M; Zhang, X et al. (2000) Reduced G-protein-coupled-receptor kinase 2 activity results in impairment of osteoblast function. Bone 27:367-73